Table 4.
Controls | Cases | ||||||
---|---|---|---|---|---|---|---|
Study Group | n | freq | n | freq | OR | (95% CI) | P |
Lung Cancer | |||||||
Iceland | 28,752 | 0.342 | 665 | 0.398 | 1.27 | (1.13 - 1.43) | 4.1 × 10−5 |
Spain | 1,474 | 0.390 | 269 | 0.483 | 1.46 | (1.22 - 1.76) | 5.4 × 10−5 |
The Netherlands | 2,018 | 0.314 | 90 | 0.350 | 1.18 | (0.86 - 1.61) | 0.31 |
Foreign combined | 3,492 | - | 359 | - | 1.38 | (1.18 - 1.62) | 6.6 × 10−5 |
All combined | 32,244 | - | 1,024 | - | 1.31 | (1.19 - 1.44) | 1.5 × 10−8 |
PAD | |||||||
Iceland | 28,752 | 0.342 | 1,503 | 0.379 | 1.18 | (1.09 - 1.27) | 5.3 × 10−5 |
New Zealand | 435 | 0.274 | 441 | 0.337 | 1.35 | (1.10 - 1.65) | 0.0041 |
Austria | 403 | 0.352 | 457 | 0.395 | 1.20 | (0.99 - 1.46) | 0.068 |
Sweden | 140 | 0.304 | 172 | 0.331 | 1.14 | (0.81 - 1.60) | 0.46 |
Italy | 234 | 0.378 | 165 | 0.412 | 1.15 | (0.86 - 1.54) | 0.33 |
Foreign combined | 1,212 | - | 1,235 | - | 1.23 | (1.09 - 1.39) | 5.9 × 10−4 |
All combined | 29,964 | - | 2,738 | - | 1.19 | (1.12 - 1.27) | 1.4 × 10−7 |